← Back to all trials
Recruiting
NCT05296889
Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical
Conditions: Spine Fracture, Degenerative Disc Disease, Spinal Instability, Spinal Tumor, Degenerative Myelopathy
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 200
Sponsor: Aesculap AG
Location: Schön Klinik Hamburg Eilbek Hamburg Free and Hanseatic City of Hamburg
Summary
Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications
Eligibility Criteria
Inclusion Criteria:
* Patient is minimum 18 years old
* Informed Consent in the documentation of clinical and radiological results
* Patient has indication according to Instructions for Use (IFU)
* Patient is not pregnant
Exclusion Criteria:
* Patient's clear unability or unwillingness to participate in follow-up examinations
Source: ClinicalTrials.gov (NCT05296889). StuddyBuddy aggregates publicly available trial information.
